137 related articles for article (PubMed ID: 19574208)
1. Mantle cell lymphoma stage IV affecting lacrimal glands, retro-orbital tissue, optic nerve and ocular motor muscles.
Pajares-Hachero B; Torres E; Hierro I; Jurado JM; Rueda A
Clin Transl Oncol; 2009 Jul; 11(7):484-5. PubMed ID: 19574208
[TBL] [Abstract][Full Text] [Related]
2. Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features.
Rasmussen PK
Acta Ophthalmol; 2013 Jul; 91 Thesis 5():1-27. PubMed ID: 24041159
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological Features of Ocular Adnexal Mantle-Cell Lymphoma in an International Multicenter Cohort.
Knudsen MKH; Rasmussen PK; Coupland SE; Esmaeli B; Finger PT; Graue GF; Grossniklaus HE; Khong JJ; McKelvie PA; Mulay K; Ralfkiaer E; Sjö LD; Vemuganti GK; Thuro BA; Curtin J; Heegaard S
JAMA Ophthalmol; 2017 Dec; 135(12):1367-1374. PubMed ID: 29121219
[TBL] [Abstract][Full Text] [Related]
4. Mantle cell lymphoma in the ocular adnexal region.
Looi A; Gascoyne RD; Chhanabhai M; Connors JM; Rootman J; White VA
Ophthalmology; 2005 Jan; 112(1):114-9. PubMed ID: 15629830
[TBL] [Abstract][Full Text] [Related]
5. Mantle cell lymphoma in the orbital and adnexal region.
Rasmussen P; Sjö LD; Prause JU; Ralfkiaer E; Heegaard S
Br J Ophthalmol; 2009 Aug; 93(8):1047-51. PubMed ID: 19429588
[TBL] [Abstract][Full Text] [Related]
6. Bilateral Lacrimal Gland Mantle Cell Lymphoma in 11-Year Follow-Up: Case Report and Review of 48 Cases With Ocular Adnexal Presentation in the Literature.
Matsuo T; Tanaka T; Okada K; Notohara K; Fujii K; Fujii N
J Investig Med High Impact Case Rep; 2023; 11():23247096231185483. PubMed ID: 37403948
[TBL] [Abstract][Full Text] [Related]
7. Antitumor activity of rituximab plus thalidomide in patients with relapsed/refractory mantle cell lymphoma.
Kaufmann H; Raderer M; Wöhrer S; Püspök A; Bankier A; Zielinski C; Chott A; Drach J
Blood; 2004 Oct; 104(8):2269-71. PubMed ID: 15166030
[TBL] [Abstract][Full Text] [Related]
8. Intensive chemotherapy and autologous stem-cell transplantation plus rituximab is superior to conventional chemotherapy for newly diagnosed advanced stage mantle-cell lymphoma: a matched pair analysis.
Mangel J; Leitch HA; Connors JM; Buckstein R; Imrie K; Spaner D; Crump M; Pennell N; Boudreau A; Berinstein NL
Ann Oncol; 2004 Feb; 15(2):283-90. PubMed ID: 14760123
[TBL] [Abstract][Full Text] [Related]
9. Update of the M. D. Anderson Cancer Center experience with hyper-CVAD and rituximab for the treatment of mantle cell and Burkitt-type lymphomas.
Fayad L; Thomas D; Romaguera J
Clin Lymphoma Myeloma; 2007 Dec; 8 Suppl 2():S57-62. PubMed ID: 18284717
[TBL] [Abstract][Full Text] [Related]
10. [Lymphoproliferative lesions of the ocular adnexa. Differential diagnostic guidelines].
Coupland SE
Ophthalmologe; 2004 Feb; 101(2):197-215; quiz 216-7. PubMed ID: 15046030
[TBL] [Abstract][Full Text] [Related]
11. Rapid complete response using intrathecal rituximab in a patient with leptomeningeal lymphomatosis due to mantle cell lymphoma.
Villela L; García M; Caballero R; Borbolla-Escoboza JR; Bolaños-Meade J
Anticancer Drugs; 2008 Oct; 19(9):917-20. PubMed ID: 18766006
[TBL] [Abstract][Full Text] [Related]
12. Lacrimal gland and extensive subcutaneous tissue involvement by mantle cell lymphoma.
Khodarahmi I; Ghesani N
Blood; 2017 Aug; 130(9):1174. PubMed ID: 28860327
[No Abstract] [Full Text] [Related]
13. Mantle Cell Lymphoma of the Lacrimal Gland.
Ana-Magadia MG; Takahashi Y; Valencia MRP; Kakizaki H
J Craniofac Surg; 2019 Jan; 30(1):158-160. PubMed ID: 30339590
[TBL] [Abstract][Full Text] [Related]
14. European phase II study of rituximab (chimeric anti-CD20 monoclonal antibody) for patients with newly diagnosed mantle-cell lymphoma and previously treated mantle-cell lymphoma, immunocytoma, and small B-cell lymphocytic lymphoma.
Foran JM; Rohatiner AZ; Cunningham D; Popescu RA; Solal-Celigny P; Ghielmini M; Coiffier B; Johnson PW; Gisselbrecht C; Reyes F; Radford JA; Bessell EM; Souleau B; Benzohra A; Lister TA
J Clin Oncol; 2000 Jan; 18(2):317-24. PubMed ID: 10637245
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of intraorbital injection of rituximab for treatment of primary ocular adnexal lymphoma: a pilot study.
Savino G; Battendieri R; Balia L; Colucci D; Larocca LM; Laurenti L; De Padua L; Blasi MA; Balestrazzi E
Cancer Sci; 2011 Aug; 102(8):1565-7. PubMed ID: 21564418
[TBL] [Abstract][Full Text] [Related]
16. Rituximab consolidation after high-dose chemotherapy and autologous blood stem cell transplantation in follicular and mantle cell lymphoma: a prospective, multicenter phase II study.
Brugger W; Hirsch J; Grünebach F; Repp R; Brossart P; Vogel W; Kopp HG; Manz MG; Bitzer M; Schlimok G; Kaufmann M; Ganser A; Fehnle K; Gramatzki M; Kanz L
Ann Oncol; 2004 Nov; 15(11):1691-8. PubMed ID: 15520073
[TBL] [Abstract][Full Text] [Related]
17. Follicular conjunctivitis caused by a mantle cell lymphoma.
Amstutz CA; Michel S; Thiel MA
Klin Monbl Augenheilkd; 2004 May; 221(5):398-400. PubMed ID: 15162290
[TBL] [Abstract][Full Text] [Related]
18. Tumours of the eye and its adnexa.
Andersen SR
Acta Ophthalmol (Copenh); 1976 Feb; 54(1):1-16. PubMed ID: 946355
[No Abstract] [Full Text] [Related]
19. Clarithromycin Leading to Complete Remission in the First-Line Treatment of Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma.
Kiesewetter B; Lukas J; Kuchar A; Mayerhoefer ME; Müllauer L; Raderer M
J Clin Oncol; 2015 Dec; 33(35):e130-2. PubMed ID: 24778391
[No Abstract] [Full Text] [Related]
20. Usefulness of second rituximab maintenance after relapse in patients with follicular and mantle cell lymphoma.
Sanchez-Gonzalez B; Gimeno E; Garcia-Pallarols F; Ancochea A; Salar A
Leuk Lymphoma; 2014 Oct; 55(10):2384-6. PubMed ID: 24601815
[No Abstract] [Full Text] [Related]
[Next] [New Search]
